Advances in stent therapy for malignant biliary obstruction.
3D printing
Drug-eluting stent
Inoperable biliary tract carcinoma
Malignant biliary obstruction
PDT
Journal
Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
pubmed:
27
5
2020
medline:
22
6
2021
entrez:
27
5
2020
Statut:
ppublish
Résumé
Malignant biliary obstruction (MBO), result of pancreatobiliary diseases is a challenging condition. Most patients with MBO are inoperable at the time of diagnosis, and the disease is poorly controlled using external-beam radiotherapy and chemotherapy. Biliary stent therapy emerged as a promising strategy for alleviating MBO and prolonging life. However, physicians find it difficult to determine the optimal type of biliary stent for the palliation of MBO. Here, we review the safety and efficacy of available biliary stents, used alone or in combination with brachytherapy, photodynamic therapy and advanced chemotherapeutics, in patients with pancreatobiliary malignancies and put forward countermeasures involving stent obstruction. Furthermore, 3D-printing stents and nanoparticle-loaded stents have broad application prospects for fabricating tailor-made biliary stents.
Identifiants
pubmed: 32451676
doi: 10.1007/s00261-020-02593-5
pii: 10.1007/s00261-020-02593-5
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
351-361Références
Valle JW, Furuse J, Jitlal M, Beare S, Mizuno N, Wasan H, Bridgewater J, Okusaka T (2014) Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials. Ann Oncol 25 (2):391-398. https://doi.org/10.1093/annonc/mdt540
doi: 10.1093/annonc/mdt540
pubmed: 24351397
pmcid: 24351397
DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245 (5):755-762. https://doi.org/10.1097/01.sla.0000251366.62632.d3
doi: 10.1097/01.sla.0000251366.62632.d3
pubmed: 17457168
pmcid: 1877058
Beyna T, Neuhaus H (2018) Self-expandable metal stents in malignant biliary obstruction: Back to the roots with uncovered stents as the "new" standard? Gastrointest Endosc 87 (4):1071-1073. https://doi.org/10.1016/j.gie.2017.11.022
doi: 10.1016/j.gie.2017.11.022
pubmed: 29571772
Gardner TB, Spangler CC, Byanova KL, Ripple GH, Rockacy MJ, Levenick JM, Smith KD, Colacchio TA, Barth RJ, Zaki BI, Tsapakos MJ, Gordon SR (2016) Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial. Gastrointest Endosc 84 (3):460-466. https://doi.org/10.1016/j.gie.2016.02.047
doi: 10.1016/j.gie.2016.02.047
pubmed: 26972022
pmcid: 4988865
Lee HW, Moon JH, Lee YN, Chung JC, Lee TH, Choi MH, Cha SW, Cho YD, Park SH (2019) Modified non-flared fully covered self-expandable metal stent versus plastic stent for preoperative biliary drainage in patients with resectable malignant biliary obstruction. J Gastroenterol Hepatol. https://doi.org/10.1111/jgh.14600
doi: 10.1111/jgh.14600
pubmed: 31758719
Fukasawa M, Takano S, Shindo H, Takahashi E, Sato T, Enomoto N (2017) Endoscopic biliary stenting for unresectable malignant hilar obstruction. Clin J Gastroenterol 10 (6):485-490. https://doi.org/10.1007/s12328-017-0778-4
doi: 10.1007/s12328-017-0778-4
pubmed: 29052124
Isayama H, Yasuda I, Ryozawa S, Maguchi H, Igarashi Y, Matsuyama Y, Katanuma A, Hasebe O, Irisawa A, Itoi T, Mukai H, Arisaka Y, Okushima K, Uno K, Kida M, Tamada K (2011) Results of a Japanese multicenter, randomized trial of endoscopic stenting for non-resectable pancreatic head cancer (JM-test): Covered Wallstent versus DoubleLayer stent. Dig Endosc 23 (4):310-315. https://doi.org/10.1111/j.1443-1661.2011.01124.x
doi: 10.1111/j.1443-1661.2011.01124.x
pubmed: 21951091
Kim JY, Ko GB, Lee TH, Park SH, Lee YN, Cho YS, Jung Y, Chung IK, Choi HJ, Cha SW, Moon JH, Cho YD, Kim SJ (2017) Partially Covered Metal Stents May Not Prolong Stent Patency Compared to Uncovered Stents in Unresectable Malignant Distal Biliary Obstruction. Gut Liver 11 (3):440-446. https://doi.org/10.5009/gnl16245
doi: 10.5009/gnl16245
pubmed: 28208003
pmcid: 5417788
Telford JJ, Carr-Locke DL, Baron TH, Poneros JM, Bounds BC, Kelsey PB, Schapiro RH, Huang CS, Lichtenstein DR, Jacobson BC, Saltzman JR, Thompson CC, Forcione DG, Gostout CJ, Brugge WR (2010) A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc 72 (5):907-914. https://doi.org/10.1016/j.gie.2010.08.021
doi: 10.1016/j.gie.2010.08.021
Shamah SP, Chapman CG, Haider H, Liao C, Waxman I, Siddiqui UD (2019) Partially Covered Versus Uncovered Self-Expandable Metal Stents: Coating Nor Diameter Affect Clinical Outcomes. Dig Dis Sci. https://doi.org/10.1007/s10620-019-05643-1
doi: 10.1007/s10620-019-05643-1
pubmed: 31041643
Yang MJ, Kim JH, Yoo BM, Hwang JC, Yoo JH, Lee KS, Kang JK, Kim SS, Lim SG, Shin SJ, Cheong JY, Lee KM, Lee KJ, Cho SW (2015) Partially covered versus uncovered self-expandable nitinol stents with anti-migration properties for the palliation of malignant distal biliary obstruction: A randomized controlled trial. Scand J Gastroenterol 50 (12):1490-1499. https://doi.org/10.3109/00365521.2015.1057219
doi: 10.3109/00365521.2015.1057219
pubmed: 26133200
Walter D, van Boeckel PG, Groenen MJ, Weusten BL, Witteman BJ, Tan G, Brink MA, Nicolai J, Tan AC, Alderliesten J, Venneman NG, Laleman W, Jansen JM, Bodelier A, Wolters FL, van der Waaij LA, Breumelhof R, Peters FT, Scheffer RC, Leenders M, Hirdes MM, Steyerberg EW, Vleggaar FP, Siersema PD (2015) Cost Efficacy of Metal Stents for Palliation of Extrahepatic Bile Duct Obstruction in a Randomized Controlled Trial. Gastroenterology 149 (1):130-138. https://doi.org/10.1053/j.gastro.2015.03.012
doi: 10.1053/j.gastro.2015.03.012
pubmed: 25790742
Soderlund C, Linder S, Bergenzaun PE, Grape T, Hakansson HO, Kilander A, Lindell G, Ljungman M, Ohlin B, Nielsen J, Rudberg C, Stotzer PO, Svartholm E, Toth E, Frozanpor F (2014) Nitinol versus steel partially covered self-expandable metal stent for malignant distal biliary obstruction: a randomized trial. Endoscopy 46 (11):941-948. https://doi.org/10.1055/s-0034-1377936
doi: 10.1055/s-0034-1377936
pubmed: 25321620
Kogure H, Ryozawa S, Maetani I, Nakai Y, Kawakami H, Yasuda I, Mochizuki H, Iwano H, Maguchi H, Kida M, Kubota K, Mukai T, Hasebe O, Igarashi Y, Hanada K, Irisawa A, Ito K, Itoi T, Isayama H (2018) A Prospective Multicenter Study of a Fully Covered Metal Stent in Patients with Distal Malignant Biliary Obstruction: WATCH-2 Study. Digestive diseases and sciences 63 (9):2466-2473. https://doi.org/10.1007/s10620-017-4875-5
doi: 10.1007/s10620-017-4875-5
pubmed: 29218484
Saleem A, Leggett CL, Murad MH, Baron TH (2011) Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc 74 (2):321-327 e321-323. https://doi.org/10.1016/j.gie.2011.03.1249
doi: 10.1016/j.gie.2011.03.1249
pubmed: 21683354
Almadi MA, Barkun AN, Martel M (2013) No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis. Clin Gastroenterol Hepatol 11 (1):27-37.e21. https://doi.org/10.1016/j.cgh.2012.10.019
doi: 10.1016/j.cgh.2012.10.019
Jang S, Stevens T, Parsi M, Lopez R, Zuccaro G, Dumot J, Vargo JJ (2018) Association of covered metallic stents with cholecystitis and stent migration in malignant biliary stricture. Gastrointest Endosc 87 (4):1061-1070. https://doi.org/10.1016/j.gie.2017.08.024
doi: 10.1016/j.gie.2017.08.024
pubmed: 28867074
Conio M, Mangiavillano B, Caruso A, Filiberti RA, Baron TH, De Luca L, Signorelli S, Crespi M, Marini M, Ravelli P, Conigliaro R, De Ceglie A (2018) Covered versus uncovered self-expandable metal stent for palliation of primary malignant extrahepatic biliary strictures: a randomized multicenter study. Gastrointest Endosc 88 (2):283-291 e283. https://doi.org/10.1016/j.gie.2018.03.029
doi: 10.1016/j.gie.2018.03.029
Lee JH, Krishna SG, Singh A, Ladha HS, Slack RS, Ramireddy S, Raju GS, Davila M, Ross WA (2013) Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients. Gastrointest Endosc 78 (2):312-324. https://doi.org/10.1016/j.gie.2013.02.032
doi: 10.1016/j.gie.2013.02.032
pubmed: 23591331
Boumitri C, Gaidhane M, Kahaleh M (2016) Antireflux metallic biliary stents: Where do we stand? Gastrointest Endosc 83 (2):413-415. https://doi.org/10.1016/j.gie.2015.10.016
doi: 10.1016/j.gie.2015.10.016
pubmed: 26773637
Hamada T, Isayama H, Nakai Y, Kogure H, Togawa O, Kawakubo K, Yamamoto N, Ito Y, Sasaki T, Tsujino T, Sasahira N, Hirano K, Tada M, Koike K (2014) Novel antireflux covered metal stent for recurrent occlusion of biliary metal stents: a pilot study. Dig Endosc 26 (2):264-269. https://doi.org/10.1111/den.12112
doi: 10.1111/den.12112
pubmed: 23621525
Zhang R, Luo H, Pan Y, Zhao L, Dong J, Liu Z, Wang X, Tao Q, Lu G, Guo X (2015) Rate of duodenal-biliary reflux increases in patients with recurrent common bile duct stones: evidence from barium meal examination. Gastrointest Endosc 82 (4):660-665. https://doi.org/10.1016/j.gie.2015.03.1908
doi: 10.1016/j.gie.2015.03.1908
Okamoto T, Fujioka S, Yanagisawa S, Yanaga K, Kakutani H, Tajiri H, Urashima M (2006) Placement of a metallic stent across the main duodenal papilla may predispose to cholangitis. Gastrointest Endosc 63 (6):792-796. https://doi.org/10.1016/j.gie.2005.05.015
doi: 10.1016/j.gie.2005.05.015
pubmed: 16650540
Weickert U, Venzke T, Konig J, Janssen J, Remberger K, Greiner L (2001) Why do bilioduodenal plastic stents become occluded? A clinical and pathological investigation on 100 consecutive patients. Endoscopy 33 (9):786-790. https://doi.org/10.1055/s-2001-16519
doi: 10.1055/s-2001-16519
pubmed: 11558033
Leung JW, Liu YL, Chan RC, Ling TK, Cheng AF (2002) Effects of adherence factors and human bile on bacterial attachment and biliary stent blockage: an in vitro study. Gastrointest Endosc 56 (1):72-77
doi: 10.1067/mge.2002.125366
Hu B, Wang TT, Wu J, Shi ZM, Gao DJ, Pan YM (2014) Antireflux stents to reduce the risk of cholangitis in patients with malignant biliary strictures: a randomized trial. Endoscopy 46 (2):120-126. https://doi.org/10.1055/s-0034-1364872
doi: 10.1055/s-0034-1364872
pubmed: 24477367
Lee YN, Moon JH, Choi HJ, Choi MH, Lee TH, Cha SW, Cho YD, Choi SY, Lee HK, Park SH (2016) Effectiveness of a newly designed antireflux valve metal stent to reduce duodenobiliary reflux in patients with unresectable distal malignant biliary obstruction: a randomized, controlled pilot study (with videos). Gastrointest Endosc 83 (2):404-412. https://doi.org/10.1016/j.gie.2015.08.084
doi: 10.1016/j.gie.2015.08.084
pubmed: 26385187
Hu B, Wang TT, Shi ZM, Wang SZ, Lu R, Pan YM, Huang H, Wang SP (2011) A novel antireflux metal stent for the palliation of biliary malignancies: a pilot feasibility study (with video). Gastrointest Endosc 73 (1):143-148. https://doi.org/10.1016/j.gie.2010.08.048
doi: 10.1016/j.gie.2010.08.048
pubmed: 20970788
Kwon CI, Moon JP, Yun H, Jeong S, Koh DH, Lee WJ, Ko KH, Kang DH (2018) Evaluation of valve function in antireflux biliary metal stents. BMC Gastroenterol 18 (1):150. https://doi.org/10.1186/s12876-018-0878-8
doi: 10.1186/s12876-018-0878-8
pubmed: 30340463
pmcid: 6194677
Choi HJ, Moon JH, Lee YN, Kim HS, Choi MH, Lee TH, Cha SW, Cho YD, Park SH, Kim SJ (2016) Evaluation of a newly modified nonflared fully covered metal stent, 12 mm in diameter, for intraductal placement in patients with malignant biliary strictures: a feasibility study. Endoscopy 48 (7):625-631. https://doi.org/10.1055/s-0042-105643
doi: 10.1055/s-0042-105643
pubmed: 27110694
Kasher JA, Corasanti JG, Tarnasky PR, McHenry L, Fogel E, Cunningham J (2011) A multicenter analysis of safety and outcome of removal of a fully covered self-expandable metal stent during ERCP. Gastrointest Endosc 73 (6):1292-1297. https://doi.org/10.1016/j.gie.2011.01.043
doi: 10.1016/j.gie.2011.01.043
pubmed: 21470603
Isayama H, Nakai Y, Toyokawa Y, Togawa O, Gon C, Ito Y, Yashima Y, Yagioka H, Kogure H, Sasaki T, Arizumi T, Matsubara S, Yamamoto N, Sasahira N, Hirano K, Tsujino T, Toda N, Tada M, Kawabe T, Omata M (2009) Measurement of radial and axial forces of biliary self-expandable metallic stents. Gastrointest Endosc 70 (1):37-44. https://doi.org/10.1016/j.gie.2008.09.032
doi: 10.1016/j.gie.2008.09.032
pubmed: 19249766
Minaga K, Kitano M, Imai H, Harwani Y, Yamao K, Kamata K, Miyata T, Omoto S, Kadosaka K, Sakurai T, Nishida N, Kudo M (2016) Evaluation of anti-migration properties of biliary covered self-expandable metal stents. World J Gastroenterol 22 (30):6917-6924. https://doi.org/10.3748/wjg.v22.i30.6917
doi: 10.3748/wjg.v22.i30.6917
pubmed: 27570427
pmcid: 4974589
Park DH, Lee SS, Lee TH, Ryu CH, Kim HJ, Seo DW, Park SH, Lee SK, Kim MH, Kim SJ (2011) Anchoring flap versus flared end, fully covered self-expandable metal stents to prevent migration in patients with benign biliary strictures: a multicenter, prospective, comparative pilot study (with videos). Gastrointest Endosc 73 (1):64-70. https://doi.org/10.1016/j.gie.2010.09.039
doi: 10.1016/j.gie.2010.09.039
pubmed: 21184871
Nakai Y, Isayama H, Kogure H, Hamada T, Togawa O, Ito Y, Matsubara S, Arizumi T, Yagioka H, Mizuno S, Sasaki T, Yamamoto N, Hirano K, Tada M, Koike K (2014) Risk factors for covered metallic stent migration in patients with distal malignant biliary obstruction due to pancreatic cancer. J Gastroenterol Hepatol 29 (9):1744-1749. https://doi.org/10.1111/jgh.12602
doi: 10.1111/jgh.12602
pubmed: 24720610
Hamada T, Isayama H, Nakai Y, Togawa O, Kogure H, Kawakubo K, Tsujino T, Sasahira N, Hirano K, Yamamoto N, Arizumi T, Ito Y, Matsubara S, Sasaki T, Yagioka H, Yashima Y, Mohri D, Miyabayashi K, Mizuno S, Nagano R, Takahara N, Toda N, Tada M, Omata M, Koike K (2011) Duodenal invasion is a risk factor for the early dysfunction of biliary metal stents in unresectable pancreatic cancer. Gastrointest Endosc 74 (3):548-555. https://doi.org/10.1016/j.gie.2011.04.046
doi: 10.1016/j.gie.2011.04.046
pubmed: 21794859
Shimizu S, Naitoh I, Nakazawa T, Hayashi K, Miyabe K, Kondo H, Yoshida M, Yamashita H, Umemura S, Hori Y, Ohara H, Joh T (2013) Predictive factors for pancreatitis and cholecystitis in endoscopic covered metal stenting for distal malignant biliary obstruction. J Gastroenterol Hepatol 28 (1):68-72. https://doi.org/10.1111/j.1440-1746.2012.07283.x
doi: 10.1111/j.1440-1746.2012.07283.x
pubmed: 23020651
Moon SH, Kim MH, Park DH, Song TJ, Eum J, Lee SS, Seo DW, Lee SK (2010) Modified fully covered self-expandable metal stents with antimigration features for benign pancreatic-duct strictures in advanced chronic pancreatitis, with a focus on the safety profile and reducing migration. Gastrointest Endosc 72 (1):86-91. https://doi.org/10.1016/j.gie.2010.01.063
doi: 10.1016/j.gie.2010.01.063
pubmed: 20493483
Cho DH, Lee SS, Oh D, Song TJ, Park DH, Seo DW, Lee SK, Kim MH (2017) Long-term outcomes of a newly developed hybrid metal stent for EUS-guided biliary drainage (with videos). Gastrointest Endosc 85 (5):1067-1075. https://doi.org/10.1016/j.gie.2016.09.010
doi: 10.1016/j.gie.2016.09.010
pubmed: 27650270
Lee HW, Moon JH, Lee YN, Lee TH, Choi MH, Cha SW, Cho YD, Park SH (2019) Usefulness of newly modified fully covered metallic stent of 12 mm in diameter and anti-migration feature for periampullary malignant biliary strictures: Comparison with conventional standard metal stent. J Gastroenterol Hepatol. https://doi.org/10.1111/jgh.14602
doi: 10.1111/jgh.14602
pubmed: 31758719
Isayama H, Kawakubo K, Nakai Y, Inoue K, Gon C, Matsubara S, Kogure H, Ito Y, Tsujino T, Mizuno S, Hamada T, Uchino R, Miyabayashi K, Yamamoto K, Sasaki T, Yamamoto N, Hirano K, Sasahira N, Tada M, Koike K (2013) A novel, fully covered laser-cut nitinol stent with antimigration properties for nonresectable distal malignant biliary obstruction: a multicenter feasibility study. Gut Liver 7 (6):725-730. https://doi.org/10.5009/gnl.2013.7.6.725
doi: 10.5009/gnl.2013.7.6.725
pubmed: 3848551
pmcid: 3848551
Bang JY, Varadarajulu S (2019) Lumen-apposing Metal Stents for EUS-guided Interventions. Dig Endosc. https://doi.org/10.1111/den.13428
doi: 10.1111/den.13428
pubmed: 31220368
Stier MW, Waxman I (2018) Lumen-Apposing Metal Stents: Which One and Why? Gastrointest Endosc Clin N Am 28 (2):207-217. https://doi.org/10.1016/j.giec.2017.11.008
doi: 10.1016/j.giec.2017.11.008
pubmed: 29519333
Aburajab M, Smith Z, Khan A, Dua K (2018) Safety and efficacy of lumen-apposing metal stents with and without simultaneous double-pigtail plastic stents for draining pancreatic pseudocyst. Gastrointest Endosc 87 (5):1248-1255. https://doi.org/10.1016/j.gie.2017.11.033
doi: 10.1016/j.gie.2017.11.033
pubmed: 29233670
Ge PS, Young JY, Dong W, Thompson CC (2019) EUS-guided gastroenterostomy versus enteral stent placement for palliation of malignant gastric outlet obstruction. Surg Endosc. https://doi.org/10.1007/s00464-018-06636-3
doi: 10.1007/s00464-018-06636-3
pubmed: 31820159
pmcid: 6684873
Kunda R, Perez-Miranda M, Will U, Ullrich S, Brenke D, Dollhopf M, Meier M, Larghi A (2016) EUS-guided choledochoduodenostomy for malignant distal biliary obstruction using a lumen-apposing fully covered metal stent after failed ERCP. Surg Endosc 30 (11):5002-5008. https://doi.org/10.1007/s00464-016-4845-6
doi: 10.1007/s00464-016-4845-6
pubmed: 26969661
Storm AC, Thompson CC (2016) Endoscopic management of sump syndrome resulting from endoscopic choledochogastrostomy. Gastrointest Endosc 83 (5):1037. https://doi.org/10.1016/j.gie.2015.11.004
doi: 10.1016/j.gie.2015.11.004
pubmed: 26578170
Tsuchiya T, Teoh AYB, Itoi T, Yamao K, Hara K, Nakai Y, Isayama H, Kitano M (2018) Long-term outcomes of EUS-guided choledochoduodenostomy using a lumen-apposing metal stent for malignant distal biliary obstruction: a prospective multicenter study. Gastrointest Endosc 87 (4):1138-1146. https://doi.org/10.1016/j.gie.2017.08.017
doi: 10.1016/j.gie.2017.08.017
pubmed: 28843583
Gupta K, Perez-Miranda M, Kahaleh M, Artifon EL, Itoi T, Freeman ML, de-Serna C, Sauer B, Giovannini M (2014) Endoscopic ultrasound-assisted bile duct access and drainage: multicenter, long-term analysis of approach, outcomes, and complications of a technique in evolution. Journal of clinical gastroenterology 48 (1):80-87. https://doi.org/10.1097/MCG.0b013e31828c6822
doi: 10.1097/MCG.0b013e31828c6822
pubmed: 23632351
Hara K, Yamao K, Hijioka S, Mizuno N, Imaoka H, Tajika M, Kondo S, Tanaka T, Haba S, Takeshi O, Nagashio Y, Obayashi T, Shinagawa A, Bhatia V, Shimizu Y, Goto H, Niwa Y (2013) Prospective clinical study of endoscopic ultrasound-guided choledochoduodenostomy with direct metallic stent placement using a forward-viewing echoendoscope. Endoscopy 45 (5):392-396. https://doi.org/10.1055/s-0032-1326076
doi: 10.1055/s-0032-1326076
pubmed: 23338620
Cheng Y, Cheng H, Jiang C, Qiu X, Wang K, Huan W, Yuan A, Wu J, Hu Y (2015) Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy. Nat Commun 6:8785. https://doi.org/10.1038/ncomms9785
doi: 10.1038/ncomms9785
pubmed: 26525216
pmcid: 4659941
Dang J, He H, Chen D, Yin L (2017) Manipulating tumor hypoxia toward enhanced photodynamic therapy (PDT). Biomater Sci 5 (8):1500-1511. https://doi.org/10.1039/c7bm00392g
doi: 10.1039/c7bm00392g
pubmed: 28681887
Anand S, Ortel BJ, Pereira SP, Hasan T, Maytin EV (2012) Biomodulatory approaches to photodynamic therapy for solid tumors. Cancer Lett 326 (1):8-16. https://doi.org/10.1016/j.canlet.2012.07.026
doi: 10.1016/j.canlet.2012.07.026
pubmed: 22842096
pmcid: 3459352
Celli JP, Spring BQ, Rizvi I, Evans CL, Samkoe KS, Verma S, Pogue BW, Hasan T (2010) Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev 110 (5):2795-2838. https://doi.org/10.1021/cr900300p
doi: 10.1021/cr900300p
pubmed: 20353192
pmcid: 2896821
Park W, Cho S, Han J, Shin H, Na K, Lee B, Kim DH (2017) Advanced smart-photosensitizers for more effective cancer treatment. Biomater Sci 6 (1):79-90. https://doi.org/10.1039/c7bm00872d
doi: 10.1039/c7bm00872d
pubmed: 29142997
pmcid: 5736440
Li X, Lee S, Yoon J (2018) Supramolecular photosensitizers rejuvenate photodynamic therapy. Chemical Society reviews 47 (4):1174-1188. https://doi.org/10.1039/c7cs00594f
doi: 10.1039/c7cs00594f
pubmed: 29334090
Bansal A, Yang F, Xi T, Zhang Y, Ho JS (2018) In vivo wireless photonic photodynamic therapy. Proceedings of the National Academy of Sciences of the United States of America 115 (7):1469-1474. https://doi.org/10.1073/pnas.1717552115
doi: 10.1073/pnas.1717552115
pubmed: 29378941
pmcid: 5816188
Bae BC, Yang SG, Jeong S, Lee DH, Na K, Kim JM, Costamagna G, Kozarek RA, Isayama H, Deviere J, Seo DW, Nageshwar Reddy D (2014) Polymeric photosensitizer-embedded self-expanding metal stent for repeatable endoscopic photodynamic therapy of cholangiocarcinoma. Biomaterials 35 (30):8487-8495. https://doi.org/10.1016/j.biomaterials.2014.07.001
doi: 10.1016/j.biomaterials.2014.07.001
pubmed: 25043500
Moole H, Tathireddy H, Dharmapuri S, Moole V, Boddireddy R, Yedama P, Dharmapuri S, Uppu A, Bondalapati N, Duvvuri A (2017) Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: A systematic review and meta-analysis. World J Gastroenterol 23 (7):1278-1288. https://doi.org/10.3748/wjg.v23.i7.1278
doi: 10.3748/wjg.v23.i7.1278
pubmed: 28275308
pmcid: 5323453
Lu Y, Liu L, Wu JC, Bie LK, Gong B (2015) Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: A meta-analysis. Clin Res Hepatol Gastroenterol 39 (6):718-724. https://doi.org/10.1016/j.clinre.2014.10.015
doi: 10.1016/j.clinre.2014.10.015
pubmed: 26070572
Cheon YK, Lee TY, Lee SM, Yoon JY, Shim CS (2012) Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma. HPB (Oxford) 14 (3):185-193. https://doi.org/10.1111/j.1477-2574.2011.00424.x
doi: 10.1111/j.1477-2574.2011.00424.x
J Y, H S, H J, Q L, Photodiagnosis ZXJ, therapy p (2016) Treatment of unresectable extrahepatic cholangiocarcinoma using hematoporphyrin photodynamic therapy: A prospective study. 16:110-118. https://doi.org/10.1016/j.pdpdt.2016.10.001
doi: 10.1016/j.pdpdt.2016.10.001
Zhang X, Mo R, Zhao H, Luo X, Yang Y (2018) A comparative effectiveness meta-analysis of photodynamic therapy and stent drainage for unresectable cholangiocarcinoma. Photodiagnosis Photodyn Ther. https://doi.org/10.1016/j.pdpdt.2018.06.018
doi: 10.1016/j.pdpdt.2018.06.018
Lim C-K, Heo J, Shin S, Jeong K, Seo YH, Jang W-D, Park CR, Park SY, Kim S, Kwon IC (2013) Nanophotosensitizers toward advanced photodynamic therapy of Cancer. Cancer Letters 334 (2):176-187. https://doi.org/10.1016/j.canlet.2012.09.012
doi: 10.1016/j.canlet.2012.09.012
pubmed: 23017942
Liu J, Yang G, Zhu W, Dong Z, Yang Y, Chao Y, Liu Z (2017) Light-controlled drug release from singlet-oxygen sensitive nanoscale coordination polymers enabling cancer combination therapy. Biomaterials 146:40-48. https://doi.org/10.1016/j.biomaterials.2017.09.007
doi: 10.1016/j.biomaterials.2017.09.007
pubmed: 28941551
Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, Lind GE, Folseraas T, Forbes SJ, Fouassier L, Geier A, Calvisi DF, Mertens JC, Trauner M, Benedetti A, Maroni L, Vaquero J, Macias RI, Raggi C, Perugorria MJ, Gaudio E, Boberg KM, Marin JJ, Alvaro D (2016) Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol 13 (5):261-280. https://doi.org/10.1038/nrgastro.2016.51
doi: 10.1038/nrgastro.2016.51
pubmed: 27095655
pmcid: 27095655
Hezel AF, Deshpande V, Zhu AX (2010) Genetics of biliary tract cancers and emerging targeted therapies. J Clin Oncol 28 (21):3531-3540. https://doi.org/10.1200/JCO.2009.27.4787
doi: 10.1200/JCO.2009.27.4787
pubmed: 20547994
pmcid: 2982782
Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362 (14):1273-1281. https://doi.org/10.1056/NEJMoa0908721
doi: 10.1056/NEJMoa0908721
pubmed: 20375404
pmcid: 20375404
Shroff RT, Javle MM, Xiao L, Kaseb AO, Varadhachary GR, Wolff RA, Raghav KPS, Iwasaki M, Masci P, Ramanathan RK, Ahn DH, Bekaii-Saab TS, Borad MJ (2019) Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2019.0270
doi: 10.1001/jamaoncol.2019.0270
pubmed: 31670748
pmcid: 6567834
Muhamad N, Plengsuriyakarn T, Na-Bangchang K (2018) Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review. Int J Nanomedicine 13:3921-3935. https://doi.org/10.2147/ijn.S165210
doi: 10.2147/ijn.S165210
pubmed: 30013345
pmcid: 6038858
HH J, SB P, JS H, HL L, YH S, J K, YH J, C K, DM K, SE L, YI J, letters KDJNr (2019) Piperlongumine-Eluting Gastrointestinal Stent Using Reactive Oxygen Species-Sensitive Nanofiber Mats for Inhibition of Cholangiocarcinoma Cells. 14 (1):58. https://doi.org/10.1186/s11671-019-2887-0
doi: 10.1186/s11671-019-2887-0
pubmed: 30778693
pmcid: 6379506
Jang SI, Lee KT, Choi JS, Jeong S, Lee DH, Kim YT, Lee SH, Yu J-S, Lee DK (2019) Efficacy of a paclitaxel-eluting biliary metal stent with sodium caprate in malignant biliary obstruction: a prospective randomized comparative study. Endoscopy 51 (9):843-851. https://doi.org/10.1055/a-0754-5763
doi: 10.1055/a-0754-5763
pubmed: 30414164
Yuan T, Zhu Y, Wang X, Cui W, Cao J (2019) Efficacy and safety evaluation of paclitaxel-loaded metal stents in patients with malignant biliary obstructions. Eur J Surg Oncol 45 (5):816-819. https://doi.org/10.1016/j.ejso.2018.10.533
doi: 10.1016/j.ejso.2018.10.533
pubmed: 30389299
Kim DH, Jeong YI, Chung CW, Kim CH, Kwak TW, Lee HM, Kang DH (2013) Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells. Int J Nanomedicine 8:1697-1711. https://doi.org/10.2147/IJN.S43508
doi: 10.2147/IJN.S43508
pubmed: 23658488
pmcid: 3646502
Lozano E, Macias RIR, Monte MJ, Asensio M, Carmen S, Sanchez‐Vicente L, Alonso‐Peña M, Al‐Abdulla R, Munoz‐Garrido P, Satriano L, O'Rourke CJ, Banales JM, Avila MA, Martinez‐Chantar ML, Andersen JB, Briz O, Marin JJG (2019) Causes of hOCT1‐Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor‐Selective Gene Therapy. Hepatology. https://doi.org/10.1002/hep.30656
doi: 10.1002/hep.30656
pubmed: 30972782
Benizri S, Ferey L, Alies B, Mebarek N, Vacher G, Appavoo A, Staedel C, Gaudin K, Barthelemy P (2018) Nucleoside-Lipid-Based Nanocarriers for Sorafenib Delivery. Nanoscale Res Lett 13 (1):17. https://doi.org/10.1186/s11671-017-2420-2
doi: 10.1186/s11671-017-2420-2
pubmed: 29327307
pmcid: 5764907
Chung MJ, Kim H, Kim KS, Park S, Chung JB, Park SW (2012) Safety evaluation of self-expanding metallic biliary stents eluting gemcitabine in a porcine model. J Gastroenterol Hepatol 27 (2):261-267. https://doi.org/10.1111/j.1440-1746.2011.06866.x
doi: 10.1111/j.1440-1746.2011.06866.x
pubmed: 21793905
Shatzel J, Kim J, Sampath K, Syed S, Saad J, Hussain ZH, Mody K, Pipas JM, Gordon S, Gardner T, Rothstein RI (2016) Drug eluting biliary stents to decrease stent failure rates: A review of the literature. World J Gastrointest Endosc 8 (2):77-85. https://doi.org/10.4253/wjge.v8.i2.77
doi: 10.4253/wjge.v8.i2.77
pubmed: 26839648
pmcid: 4724033
Roy R, Maraveyas A (2010) Chemoradiation in pancreatic adenocarcinoma: a literature review. Oncologist 15 (3):259-269. https://doi.org/10.1634/theoncologist.2009-0272
doi: 10.1634/theoncologist.2009-0272
pubmed: 20203172
pmcid: 3227952
Kopek N, Holt MI, Hansen AT, Hoyer M (2010) Stereotactic body radiotherapy for unresectable cholangiocarcinoma. Radiother Oncol 94 (1):47-52. https://doi.org/10.1016/j.radonc.2009.11.004
doi: 10.1016/j.radonc.2009.11.004
pubmed: 19963295
Pagáčová E, Štefančíková L, Schmidt-Kaler F, Hildenbrand G, Vičar T, Depeš D, Lee J-H, Bestvater F, Lacombe S, Porcel E, Roux S, Wenz F, Kopečná O, Falková I, Hausmann M, Falk M (2019) Challenges and Contradictions of Metal Nano-Particle Applications for Radio-Sensitivity Enhancement in Cancer Therapy. International journal of molecular sciences 20 (3):588. https://doi.org/10.3390/ijms20030588
doi: 10.3390/ijms20030588
pmcid: 6387067
Misra R, Sarkar K, Lee J, Pizzuti VJ, Lee DS, Currie MP, Torregrosa-Allen SE, Long DE, Durm GA, Langer MP, Elzey BD, Won YY (2019) Radioluminescent nanoparticles for radiation-controlled release of drugs. Journal of controlled release : official journal of the Controlled Release Society 303:237-252. https://doi.org/10.1016/j.jconrel.2019.04.033
doi: 10.1016/j.jconrel.2019.04.033
Hu P, Fu Z, Liu G, Tan H, Xiao J, Shi H, Cheng D (2019) Gadolinium-Based Nanoparticles for Theranostic MRI-Guided Radiosensitization in Hepatocellular Carcinoma. Front Bioeng Biotechnol 7:368-368. https://doi.org/10.3389/fbioe.2019.00368
doi: 10.3389/fbioe.2019.00368
pubmed: 31828068
pmcid: 6890599
Xu X, Li J, Wu J, Zhu R, Ji W (2018) A Systematic Review and Meta-analysis of Intraluminal Brachytherapy Versus Stent Alone in the Treatment of Malignant Obstructive Jaundice. Cardiovasc Intervent Radiol 41 (2):206-217. https://doi.org/10.1007/s00270-017-1827-6
doi: 10.1007/s00270-017-1827-6
pubmed: 29075881
Ma J, Luo J, Gu J, Liu Q, Liu L, Zhang W, Zhang Z, Yan Z (2018) Malignant obstructive jaundice treated with intraluminal placement of Iodine-125 seed strands and metal stents: An analysis of long-term outcomes and prognostic features. Brachytherapy 17 (4):689-695. https://doi.org/10.1016/j.brachy.2018.04.001
doi: 10.1016/j.brachy.2018.04.001
Hasimu A, Gu JP, Ji WZ, Zhang HX, Zhu DW, Ren WX (2017) Comparative Study of Percutaneous Transhepatic Biliary Stent Placement with or without Iodine-125 Seeds for Treating Patients with Malignant Biliary Obstruction. J Vasc Interv Radiol 28 (4):583-593. https://doi.org/10.1016/j.jvir.2016.11.038
doi: 10.1016/j.jvir.2016.11.038
pubmed: 28162906
Liao WC, Chien KL, Lin YL, Wu MS, Lin JT, Wang HP, Tu YK (2013) Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. The Lancet Oncology 14 (11):1095-1103. https://doi.org/10.1016/s1470-2045(13)70388-7
doi: 10.1016/s1470-2045(13)70388-7
pubmed: 24035532
Tanderup K, Menard C, Polgar C, Lindegaard JC, Kirisits C, Potter R (2017) Advancements in brachytherapy. Adv Drug Deliv Rev 109:15-25. https://doi.org/10.1016/j.addr.2016.09.002
doi: 10.1016/j.addr.2016.09.002
pubmed: 27637454
Strnad V, Hannoun-Levi JM, Guinot JL, Lossl K, Kauer-Dorner D, Resch A, Kovacs G, Major T, Van Limbergen E (2015) Recommendations from GEC ESTRO Breast Cancer Working Group (I): Target definition and target delineation for accelerated or boost Partial Breast Irradiation using multicatheter interstitial brachytherapy after breast conserving closed cavity surgery. Radiother Oncol 115 (3):342-348. https://doi.org/10.1016/j.radonc.2015.06.010
doi: 10.1016/j.radonc.2015.06.010
pubmed: 26104975
Zhu HD, Guo JH, Huang M, Ji JS, Xu H, Lu J, Li HL, Wang WH, Li YL, Ni CF, Shi HB, Xiao EH, Lv WF, Sun JH, Xu K, Han GH, Du LA, Ren WX, Li MQ, Mao AW, Xiang H, Zhang KX, Min J, Zhu GY, Su C, Chen L, Teng GJ (2018) Irradiation stents vs. conventional metal stents for unresectable malignant biliary obstruction: A multicenter trial. J Hepatol 68 (5):970-977. https://doi.org/10.1016/j.jhep.2017.12.028
doi: 10.1016/j.jhep.2017.12.028
pubmed: 29331343
Wang W, Li P, Wang Y, Liu B, Li Y (2019) Percutaneous stenting and chemotherapy for unresectable pancreatic cancer: Comparison of irradiation stents vs conventional metal stents. Pancreatology : official journal of the International Association of Pancreatology (IAP) [et al] 19 (7):957-962. https://doi.org/10.1016/j.pan.2019.09.006
doi: 10.1016/j.pan.2019.09.006
pubmed: 31551162
Jiao D, Wu G, Ren J, Han X (2017) Study of self-expandable metallic stent placement intraluminal (125)I seed strands brachytherapy of malignant biliary obstruction. Surg Endosc 31 (12):4996-5005. https://doi.org/10.1007/s00464-017-5481-5
doi: 10.1007/s00464-017-5481-5
pubmed: 28643064
Wang P, Que W, Zhang M, Dai X, Yu K, Wang C, Peng Z, Zhong L (2019) Application of 3-Dimensional Printing in Pediatric Living Donor Liver Transplantation: A Single-Center Experience. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. https://doi.org/10.1002/lt.25435
doi: 10.1002/lt.25435
pubmed: 31436367
pmcid: 6864229
Ware MJ, Keshishian V, Law JJ, Ho JC, Favela CA, Rees P, Smith B, Mohammad S, Hwang RF, Rajapakshe K, Coarfa C, Huang S, Edwards DP, Corr SJ, Godin B, Curley SA (2016) Generation of an in vitro 3D PDAC stroma rich spheroid model. Biomaterials 108:129-142. https://doi.org/10.1016/j.biomaterials.2016.08.041
doi: 10.1016/j.biomaterials.2016.08.041
pubmed: 27627810
pmcid: 5082237
Zeng N, Fang CH, Fan YF, Yang J, Xiang N, Zhu W, Liu J, Cai W, Mo ZK (2016) [The construction of three-dimensional visualization platform and its application in diagnosis and treatment for hilar cholangiocarcinoma]. Zhonghua wai ke za zhi [Chinese journal of surgery] 54 (9):680-685. https://doi.org/10.3760/cma.j.issn.0529-5815.2016.09.007
doi: 10.3760/cma.j.issn.0529-5815.2016.09.007
Fang CH, Zhang P, Lau YY, Zhong SZ (2019) [Construction and application of the core technology system of digital intelligent diagnostic and treatment for hepato-biliary-pancreatic diseases]. Zhonghua wai ke za zhi [Chinese journal of surgery] 57 (4):253-257. https://doi.org/10.3760/cma.j.issn.0529-5815.2019.04.003
doi: 10.3760/cma.j.issn.0529-5815.2019.04.003
Li Z, Loh XJ (2015) Water soluble polyhydroxyalkanoates: future materials for therapeutic applications. Chemical Society reviews 44 (10):2865-2879. https://doi.org/10.1039/c5cs00089k
doi: 10.1039/c5cs00089k
pubmed: 25788317
Mauri G, Michelozzi C, Melchiorre F, Poretti D, Pedicini V, Salvetti M, Criado E, Falco Fages J, De Gregorio MA, Laborda A, Sonfienza LM, Cornalba G, Monfardini L, Panek J, Andrasina T, Gimenez M (2016) Benign biliary strictures refractory to standard bilioplasty treated using polydoxanone biodegradable biliary stents: retrospective multicentric data analysis on 107 patients. European radiology 26 (11):4057-4063. https://doi.org/10.1007/s00330-016-4278-6
doi: 10.1007/s00330-016-4278-6
pubmed: 26943135
Ventola CL (2014) Medical Applications for 3D Printing: Current and Projected Uses. P & T : a peer-reviewed journal for formulary management 39 (10):704-711
Lin M, Firoozi N, Tsai CT, Wallace MB, Kang Y (2019) 3D-printed flexible polymer stents for potential applications in inoperable esophageal malignancies. Acta Biomater 83:119-129. https://doi.org/10.1016/j.actbio.2018.10.035
doi: 10.1016/j.actbio.2018.10.035
pubmed: 30366130
Misra SK, Ostadhossein F, Babu R, Kus J, Tankasala D, Sutrisno A, Walsh KA, Bromfield CR, Pan D (2017) 3D-Printed Multidrug-Eluting Stent from Graphene-Nanoplatelet-Doped Biodegradable Polymer Composite. Adv Healthc Mater 6 (11). https://doi.org/10.1002/adhm.201700008
doi: 10.1002/adhm.201700008
pubmed: 28322012
Xu J, Ong HX, Traini D, Byrom M, Williamson J, Young PM (2019) The utility of 3D-printed airway stents to improve treatment strategies for central airway obstructions. Drug Dev Ind Pharm 45 (1):1-10. https://doi.org/10.1080/03639045.2018.1522325
doi: 10.1080/03639045.2018.1522325
pubmed: 30207189
Boyer CJ, Boktor M, Samant H, White LA, Wang Y, Ballard DH, Huebert RC, Woerner JE, Ghali GE, Alexander JS (2019) 3D Printing for Bio-Synthetic Biliary Stents. Bioengineering (Basel) 6 (1). https://doi.org/10.3390/bioengineering6010016
doi: 10.3390/bioengineering6010016
Wang AY, Ellen K, Berg CL, Schmitt TM, Kahaleh M (2009) Fully covered self-expandable metallic stents in the management of complex biliary leaks: preliminary data - a case series. Endoscopy 41 (9):781-786. https://doi.org/10.1055/s-0029-1215050
doi: 10.1055/s-0029-1215050
pubmed: 19693751
Gwon DI, Lee SS, Kim EY (2012) Cefotaxime-eluting covered self-expandable stents in a canine biliary model: scanning electron microscopic study of biofilm formation. Acta radiologica (Stockholm, Sweden : 1987) 53 (10):1127-1132. https://doi.org/10.1258/ar.2012.120220
doi: 10.1258/ar.2012.120220
Wu D, Fan W, Kishen A, Gutmann JL, Fan B (2014) Evaluation of the antibacterial efficacy of silver nanoparticles against Enterococcus faecalis biofilm. Journal of endodontics 40 (2):285-290. https://doi.org/10.1016/j.joen.2013.08.022
doi: 10.1016/j.joen.2013.08.022
pubmed: 24461420
Vaishnavi C, Samanta J, Kochhar R (2018) Characterization of biofilms in biliary stents and potential factors involved in occlusion. World J Gastroenterol 24 (1):112-123. https://doi.org/10.3748/wjg.v24.i1.112
doi: 10.3748/wjg.v24.i1.112
pubmed: 29358888
pmcid: 5757116
Wen W, Ma LM, He W, Tang XW, Zhang Y, Wang X, Liu L, Fan ZN (2016) Silver-nanoparticle-coated biliary stent inhibits bacterial adhesion in bacterial cholangitis in swine. Hepatobiliary & pancreatic diseases international : HBPD INT 15 (1):87-92
doi: 10.1016/S1499-3872(15)60410-6
Lee TH, Jang BS, Jung MK, Pack CG, Choi JH, Park DH (2016) Fabrication of a silver particle-integrated silicone polymer-covered metal stent against sludge and biofilm formation and stent-induced tissue inflammation. Sci Rep 6:35446. https://doi.org/10.1038/srep35446
doi: 10.1038/srep35446
pubmed: 27739486
pmcid: 5064322
Yang F, Ren Z, Chai Q, Cui G, Jiang L, Chen H, Feng Z, Chen X, Ji J, Zhou L, Wang W, Zheng S (2016) A novel biliary stent coated with silver nanoparticles prolongs the unobstructed period and survival via anti-bacterial activity. Sci Rep 6:21714. https://doi.org/10.1038/srep21714
doi: 10.1038/srep21714
pubmed: 26883081
pmcid: 4756318
Park JH, Park W, Cho S, Kim KY, Tsauo J, Yoon SH, Son WC, Kim DH, Song HY (2018) Nanofunctionalized Stent-Mediated Local Heat Treatment for the Suppression of Stent-Induced Tissue Hyperplasia. ACS Appl Mater Interfaces 10 (35):29357-29366. https://doi.org/10.1021/acsami.8b09819
doi: 10.1021/acsami.8b09819
pubmed: 30086241
pmcid: 7050633